Skip to main content
Home
Home
  • Register here
  • Sign In
  • Home
  • News Feed
  • Therapeutic areas
    • Cardio-Metabolic
      • Heart Failures
      • Dyslipidemia
    • Dermatology
      • Psoriasis (PsO)
    • Rheumatology
      • Spondyloarthritis
    • Ophthalmology
      • Ophthalmology
    • Respiratory
      • BLOCK IgE; UNLOCK LIFE in 3 indications
      • IgE-Related Chronic Diseases
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Melanoma
      • Oncology Publication
    • Hematology
      • CML
      • ITP
      • MPN
      • SAA
    • Transplant
      • Transplant
    • Neurology
      • Dementia
    • Rare Disease
      • Spinal Muscular Atrophy (SMA)
  • Exclusive event
  • Pharma Corner

Popular Search

  • heart
  • heart failure
  • medical
  • medical information/c
  • dme

Recent News

IgE-Related Chronic Diseases TISTOK
LIPID Management and CVD Forum 2024
PEAK 2024 (SAA & MPN)
Search
  1. VDO test

https://www.kaltura.com/index.php/extwidget/preview/partner_id/2076321/uiconf_id/46737343/entry_id/1_5xrpv9k9/embed/iframe?

×

Medical Information Request

×

Ask Speakers

Latest Content

Allergic Disease

IgE-Related Chronic Diseases Webinar

Upcoming Webinar New Release Snapshot: Decision chart in the most prevalent phenotypes of severe asthma

Show More

Print
Rheumatology Associations Event

Rheumatology Associations Event

24th Asia-Pacific League of Associations for Rheumatology Congress 2022 - APLAR Congress 2022 ACR Convergence ProgramShow More
Print
Webinar

Spondyloarthritis Webinar

Upcoming Webinar Upcoming Webinar New Release 2023 South-East Asia Psoriatic Disease Conclave

Watch the video Show More

Print
Prescription Information

Spondyloarthritis Prescription information

MIMS Read moreShow More
Print
Guideline

Spondyloarthritis Guidelines

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Gossec L, Baraliakos X, Kerschbaumer A, et al May 2020 DOI: 10.1136/annrheumdis-2020-217159

Checkout

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

VanShow More

Print
Publication

Spondyloarthritis Publication

Oct 2015

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

Philip J. Mease, M.D., Iain B. McInnes, Ph.D and et al.

Checkout

Nov 2022

Secukinumab Provides Sustained Improvements in the Signs andShow More
Print
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
 of  38
Sitemap
©2025 Novartis Pharma
  • Terms of use
  • Privacy
The site is intended for HCP local audiences